Literature DB >> 11994477

Critical role of signaling through IL-1 receptor for development of arthritis and sepsis during Staphylococcus aureus infection.

Olof H Hultgren1, Lena Svensson, Andrej Tarkowski.   

Abstract

IL-1R-deficient mice (IL-1R(-/-)) and their wild-type controls (IL-1R(+/+)) were i.v. inoculated with 1 x 10(7) or 10(6) Staphylococcus aureus per mouse to mimic bacterial sepsis and septic arthritis. The disease outcome was severely worsened in the IL-1R(-/-) mice as compared with IL-1R(+/+) mice. Indeed, 3 days after inoculation of 10(7) S. aureus per mouse 84% of IL-1R(-/-) mice displayed clinical signs of septicemia as compared with none of the IL-1R(+/+) mice. On day 9 after inoculation with 10(6) S. aureus per mouse 75% of the IL-1R(-/-) mice were dead as compared with none of the IL-1R(+/+) mice. Also, the number of staphylococci in circulation was 25- to 30-fold increased in IL-1R(-/-) mice as compared with IL-1R(+/+) mice, the most probable reason for the outcome. The frequency and severity of septic arthritis were significantly increased in IL-1R(-/-) mice, as compared with IL-1R(+/+) mice, following i.v. inoculation of staphylococci. This was probably due to an increased accumulation of bacteria in the joints of IL-1R(-/-) mice as compared with their wild-type controls. Interestingly, while serum levels of IL-18 in IL-1R(-/-) mice were significantly lower than in IL-1R(+/+) mice 24 h after inoculation of S. aureus, both IL-18 and IL-1beta were significantly increased in IL-1R(-/-) vs IL-1R(+/+) mice 4 days after the bacterial inoculation. In conclusion, IL-1R signaling plays a crucial role in host protection during systemic S. aureus infection as seen by the fatal outcome of S. aureus sepsis and arthritis in IL-1R-deficient mice.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11994477     DOI: 10.4049/jimmunol.168.10.5207

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  33 in total

1.  Staphylococcus aureus evades lysozyme-based peptidoglycan digestion that links phagocytosis, inflammasome activation, and IL-1beta secretion.

Authors:  Takahiro Shimada; Bong Goo Park; Andrea J Wolf; Constantinos Brikos; Helen S Goodridge; Courtney A Becker; Christopher N Reyes; Edward A Miao; Alan Aderem; Friedrich Götz; George Y Liu; David M Underhill
Journal:  Cell Host Microbe       Date:  2010-01-21       Impact factor: 21.023

2.  Role of fibronectin-binding proteins A and B in in vitro cellular infections and in vivo septic infections by Staphylococcus aureus.

Authors:  Hitomi Shinji; Yukio Yosizawa; Akiko Tajima; Tadayuki Iwase; Shinya Sugimoto; Keiko Seki; Yoshimitsu Mizunoe
Journal:  Infect Immun       Date:  2011-03-21       Impact factor: 3.441

3.  Interleukin-1 and host control of pulmonary histoplasmosis.

Authors:  George S Deepe; Michael McGuinness
Journal:  J Infect Dis       Date:  2006-08-10       Impact factor: 5.226

Review 4.  The NLRP3 inflammasome in health and disease: the good, the bad and the ugly.

Authors:  P Menu; J E Vince
Journal:  Clin Exp Immunol       Date:  2011-07-15       Impact factor: 4.330

5.  Synergistic Action of Staphylococcus aureus α-Toxin on Platelets and Myeloid Lineage Cells Contributes to Lethal Sepsis.

Authors:  Michael E Powers; Russell E N Becker; Anne Sailer; Jerrold R Turner; Juliane Bubeck Wardenburg
Journal:  Cell Host Microbe       Date:  2015-06-10       Impact factor: 21.023

6.  Sensing of interleukin-1 cytokines during Streptococcus pneumoniae colonization contributes to macrophage recruitment and bacterial clearance.

Authors:  Jamie K Lemon; Megan R Miller; Jeffrey N Weiser
Journal:  Infect Immun       Date:  2015-06-01       Impact factor: 3.441

7.  Protective role of IL-1β against post-arthroplasty Staphylococcus aureus infection.

Authors:  Nicholas M Bernthal; Jonathan R Pribaz; Alexandra I Stavrakis; Fabrizio Billi; John S Cho; Romela Irene Ramos; Kevin P Francis; Yoichiro Iwakura; Lloyd S Miller
Journal:  J Orthop Res       Date:  2011-03-28       Impact factor: 3.494

8.  The interleukin-1β/CXCL1/2/neutrophil axis mediates host protection against group B streptococcal infection.

Authors:  C Biondo; G Mancuso; A Midiri; G Signorino; M Domina; V Lanza Cariccio; N Mohammadi; M Venza; I Venza; G Teti; C Beninati
Journal:  Infect Immun       Date:  2014-08-11       Impact factor: 3.441

Review 9.  Targeting the host-pathogen interface for treatment of Staphylococcus aureus infection.

Authors:  Bonggoo Park; George Y Liu
Journal:  Semin Immunopathol       Date:  2011-11-17       Impact factor: 9.623

10.  Septic arthritis in the native joint.

Authors:  Meghan B Brennan; Jennifer L Hsu
Journal:  Curr Infect Dis Rep       Date:  2012-10       Impact factor: 3.725

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.